A detailed history of Danske Bank A/S transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Danske Bank A/S holds 31,668 shares of BMY stock, worth $1.48 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
31,668
Holding current value
$1.48 Million
% of portfolio
0.07%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 19, 2025

BUY
$43.31 - $48.98 $67.4 Million - $76.2 Million
1,555,709 Added 4912.56%
1,587,377 $71.6 Million
Q3 2025

Nov 13, 2025

BUY
$43.31 - $48.98 $1.37 Million - $1.55 Million
31,668 New
31,668 $1.43 Billion
Q2 2025

Dec 18, 2025

SELL
$44.12 - $59.6 $14.4 Million - $19.5 Million
-327,066 Reduced 19.8%
1,324,692 $61.3 Million
Q1 2025

Dec 18, 2025

BUY
$53.9 - $63.11 $3.47 Million - $4.06 Million
64,381 Added 4.06%
1,651,758 $101 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $99.5B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Danske Bank A/S Portfolio

Follow Danske Bank A/S and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Danske Bank A/S, based on Form 13F filings with the SEC.

News

Stay updated on Danske Bank A/S with notifications on news.